-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 EruDUFGkMx5fB2Kh/OrDZ+iloZn1wad7CJRRCUI/R9gxHh51dS1Q9feUSTxnDyBl
 lIlEvAURAVoPE3U2dlHnVQ==

<SEC-DOCUMENT>0001209191-08-012132.txt : 20080221
<SEC-HEADER>0001209191-08-012132.hdr.sgml : 20080221
<ACCEPTANCE-DATETIME>20080221174146
ACCESSION NUMBER:		0001209191-08-012132
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080109
FILED AS OF DATE:		20080221
DATE AS OF CHANGE:		20080221

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JAVELIN PHARMACEUTICALS, INC
		CENTRAL INDEX KEY:			0000050710
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880471759
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		125 CAMBRIDGEPARK DRIVE
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02140
		BUSINESS PHONE:		617-349-4500

	MAIL ADDRESS:	
		STREET 1:		125 CAMBRIDGEPARK DRIVE
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02140

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTRAC INC
		DATE OF NAME CHANGE:	20010313

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Tulipano Stephen J
		CENTRAL INDEX KEY:			0001360548

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32949
		FILM NUMBER:		08633933

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		212-554-4550

	MAIL ADDRESS:	
		STREET 1:		C/O JAVELIN PHARMACEUTICALS, INC.
		STREET 2:		130 WEST 42ND STREET - 12TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>bny47880_bny01sjt.xml
<DESCRIPTION>MAIN DOCUMENT DESCRIPTION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-01-09</periodOfReport>

    <issuer>
        <issuerCik>0000050710</issuerCik>
        <issuerName>JAVELIN PHARMACEUTICALS, INC</issuerName>
        <issuerTradingSymbol>JAV</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001360548</rptOwnerCik>
            <rptOwnerName>Tulipano Stephen J</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O JAVELIN PHARMACEUTICALS</rptOwnerStreet1>
            <rptOwnerStreet2>125 CAMBRIDGEPARK DRIVE</rptOwnerStreet2>
            <rptOwnerCity>CAMBRIDGE</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>02140</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Financial Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable></nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.53</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2008-01-09</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>60000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2018-01-08</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>60000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>60000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Granted under the Amended and Restated 2005 Stock Incentive Plan.</footnote>
        <footnote id="F2">Vesting in three equal annual installments beginning after the first year.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Stephen J. Tulipano</signatureName>
        <signatureDate>2008-02-07</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----